Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron T Gerds

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Oncology|January 18, 2017
Polycythemia Vera Management and Challenges in the Community Health SettingAaron T Gerds, Kim-Hien Dao
Current Hematologic Malignancy Reports|October 16, 2012
Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditionsAaron T Gerds, Bart L Scott
Expert Review of Anticancer Therapy|June 28, 2022
Targeting the PI3K pathway in myeloproliferative neoplasmsAaron T Gerds, Niccolo Bartalucci, Albert Assad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Emerging importance of mutational analysis in myelodysplastic syndrome and acute myelogenous leukemiaAaron T Gerds, Matthew J Walter, Bart L Scott
Current Hematologic Malignancy Reports|February 13, 2020
Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health SpanShimoli V Barot, Bhumika J Patel, Aaron T Gerds
Blood|May 11, 2013
Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndromeAaron T Gerds, Ted A Gooley, Wendy A Wilson, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 21, 2025
A Review of Real-World Experience With Ruxolitinib for MyelofibrosisHaifa Kathrin Al-Ali, Aaron T Gerds, Michael R Grunwald, et al.
Leukemia & Lymphoma|April 21, 2023
Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacyNaveen Pemmaraju, Prithviraj Bose, Raajit Rampal, et al.
Annals of Hematology|December 3, 2019
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinionSophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Annals of Hematology|October 26, 2019
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinionSophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Oncology|January 18, 2017
Polycythemia Vera Management and Challenges in the Community Health SettingAaron T Gerds, Kim-Hien Dao
Current Hematologic Malignancy Reports|October 16, 2012
Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditionsAaron T Gerds, Bart L Scott
Expert Review of Anticancer Therapy|June 28, 2022
Targeting the PI3K pathway in myeloproliferative neoplasmsAaron T Gerds, Niccolo Bartalucci, Albert Assad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Emerging importance of mutational analysis in myelodysplastic syndrome and acute myelogenous leukemiaAaron T Gerds, Matthew J Walter, Bart L Scott
Current Hematologic Malignancy Reports|February 13, 2020
Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health SpanShimoli V Barot, Bhumika J Patel, Aaron T Gerds
Blood|May 11, 2013
Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndromeAaron T Gerds, Ted A Gooley, Wendy A Wilson, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 21, 2025
A Review of Real-World Experience With Ruxolitinib for MyelofibrosisHaifa Kathrin Al-Ali, Aaron T Gerds, Michael R Grunwald, et al.
Leukemia & Lymphoma|April 21, 2023
Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacyNaveen Pemmaraju, Prithviraj Bose, Raajit Rampal, et al.
Annals of Hematology|December 3, 2019
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinionSophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Annals of Hematology|October 26, 2019
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinionSophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Pageof 14